Steris | STE - Net Income



Steris reported $177.4M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
3M USD 723M 393M Jun/2025
Avanos Medical USD -76800000 83.4M Jun/2025
Baxter International USD 91M 35M Jun/2025
Becton, Dickinson and Co. USD 574M 266M Jun/2025
Boston Scientific USD 797M 123M Jun/2025
CONMED USD 21.42M 15.38M Jun/2025
Cooper Companies USD 98.3M 10.6M Jul/2025
Dexcom USD 179.8M 74.4M Jun/2025
Ecolab USD 524.2M 121.7M Jun/2025
Edwards Lifesciences USD 333.2M 24.8M Jun/2025
Fortive USD 166.6M 5.3M Jun/2025
Getinge SEK 662M 661M Dec/2024
Globus Medical USD 202.85M 127.38M Jun/2025
Haemonetics USD 34.03M 23.95M Jun/2025
Hologic USD 194.9M 212.3M Jun/2025
Idexx Laboratories USD 293.99M 51.31M Jun/2025
Insulet USD 22.5M 12.9M Jun/2025
Integra LifeSciences USD -484073000 458.78M Jun/2025
Intuitive Surgical USD 658.4M 40M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Masimo USD 51.3M 222M Jun/2025
Olympus JPY 8.99B 32.48B Jun/2025
Owens Minor USD -24982000 271.13M Mar/2025
ResMed USD 379.7M 14.66M Jun/2025
Steris USD 177.4M 31.73M Jun/2025
Stryker USD 884M 230M Jun/2025
Tandem Diabetes Care USD -52400000 78.16M Jun/2025
Teleflex USD 122.58M 27.58M Jun/2025
Thermo Fisher Scientific USD 1.62B 110M Jun/2025
Zimmer Biomet Holdings USD 152.8M 29.2M Jun/2025